• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种自动免疫分析方法检测爱泼斯坦-巴尔病毒特异性免疫球蛋白M的比较

Comparison of three automated immunoassay methods for the determination of Epstein-Barr virus-specific immunoglobulin M.

作者信息

Berth Mario, Bosmans Eugene

机构信息

Algemeen Medisch Laboratorium, Immunology Department, Desguinlei 88, 2018 Antwerp, Belgium.

出版信息

Clin Vaccine Immunol. 2010 Apr;17(4):559-63. doi: 10.1128/CVI.00372-09. Epub 2010 Feb 10.

DOI:10.1128/CVI.00372-09
PMID:20147496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2849340/
Abstract

In this study we compared the performances of three commercially available Epstein-Barr virus (EBV) immunoglobulin M (IgM) assays on highly automated immunoassay platforms: BioPlex 2200 (Bio-Rad Laboratories), Immulite 2000 (Siemens Healthcare Diagnostics), and Liaison (DiaSorin). As a confirmatory method, immunoblotting was performed. The specificity of the three EBV IgM assays was evaluated by testing 293 selected sera from patients with various infectious and noninfectious diseases. After the exclusion of 30 samples, the specificities were 96.2% for Liaison, 98.1% for Immulite, and 97.0% for BioPlex. For evaluation of the sensitivity, samples from 70 consecutive patients with a positive heterophile antibody test were examined, irrespective of clinical or biological findings. After the exclusion of six samples, the sensitivities were 89.1% for Liaison, 84.4% for Immulite, and 89.1% for BioPlex. Finally, in a prospective study performed with 500 samples obtained from consecutive patients and sent in by general practitioners, we also determined Epstein-Barr nuclear antigen IgG and viral capsid antigen IgG in a two-phase approach. Concordance of the EBV serologic status was 96.2% between Liaison and Immulite, 96.4% between Immulite and BioPlex, and 97.8% between BioPlex and Liaison. The three EBV IgM immunoassays that we evaluated have acceptable and comparable performances.

摘要

在本研究中,我们比较了三种市售的爱泼斯坦-巴尔病毒(EBV)免疫球蛋白M(IgM)检测方法在高度自动化免疫分析平台上的性能:BioPlex 2200(伯乐公司)、Immulite 2000(西门子医疗诊断公司)和Liaison(索灵公司)。采用免疫印迹法作为确证方法。通过检测从患有各种感染性和非感染性疾病的患者中选取的293份血清,评估这三种EBV IgM检测方法的特异性。排除30份样本后,Liaison的特异性为96.2%,Immulite为98.1%,BioPlex为97.0%。为评估敏感性,检查了70例嗜异性抗体检测呈阳性的连续患者的样本,无论其临床或生物学检查结果如何。排除6份样本后,Liaison的敏感性为89.1%,Immulite为84.4%,BioPlex为89.1%。最后,在一项对全科医生送来的500份连续患者样本进行的前瞻性研究中,我们还采用两阶段方法测定了爱泼斯坦-巴尔核抗原IgG和病毒衣壳抗原IgG。Liaison与Immulite之间的EBV血清学状态一致性为96.2%,Immulite与BioPlex之间为96.4%,BioPlex与Liaison之间为97.8%。我们评估的三种EBV IgM免疫分析方法具有可接受的且相当的性能。

相似文献

1
Comparison of three automated immunoassay methods for the determination of Epstein-Barr virus-specific immunoglobulin M.三种自动免疫分析方法检测爱泼斯坦-巴尔病毒特异性免疫球蛋白M的比较
Clin Vaccine Immunol. 2010 Apr;17(4):559-63. doi: 10.1128/CVI.00372-09. Epub 2010 Feb 10.
2
Comparison of Abbott Architect, Siemens Immulite, and Diasorin Liaison for determination of Epstein-Barr virus serological diagnosis.比较雅培Architect、西门子Immulite和索灵Liaison在爱泼斯坦-巴尔病毒血清学诊断测定中的表现。
Diagn Microbiol Infect Dis. 2018 Feb;90(2):96-101. doi: 10.1016/j.diagmicrobio.2017.10.020. Epub 2017 Nov 7.
3
Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas, and Euroimmune assays for determination of Epstein-Barr virus serological diagnosis.评价 Abbott Architect、Siemens Immulite、bioMerieux Vidas 和 Euroimmune 检测试剂盒用于 EB 病毒血清学诊断的性能。
J Med Virol. 2021 Nov;93(11):6309-6316. doi: 10.1002/jmv.27262. Epub 2021 Aug 17.
4
Evaluation of a multiplex flow immunoassay for detection of epstein-barr virus-specific antibodies.用于检测爱泼斯坦-巴尔病毒特异性抗体的多重流式免疫分析的评估
Clin Vaccine Immunol. 2008 Sep;15(9):1410-3. doi: 10.1128/CVI.00082-08. Epub 2008 Jul 16.
5
Analytical performance evaluation of the Elecsys Epstein-Barr virus immunoassay panel.罗氏电化学发光法检测爱泼斯坦-巴尔病毒免疫分析试剂盒的分析性能评估
Diagn Microbiol Infect Dis. 2021 Nov;101(3):115443. doi: 10.1016/j.diagmicrobio.2021.115443. Epub 2021 May 29.
6
Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status.两种市售自动化免疫测定法用于确定爱泼斯坦-巴尔病毒血清学状态的性能。
Clin Vaccine Immunol. 2012 Jun;19(6):929-34. doi: 10.1128/CVI.00100-12. Epub 2012 Apr 25.
7
Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.用于评估爱泼斯坦-巴尔病毒免疫状态的多重微珠检测法的评估
J Clin Microbiol. 2004 Nov;42(11):4996-5000. doi: 10.1128/JCM.42.11.4996-5000.2004.
8
Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.以免疫荧光法为参考方法,评估Architect爱泼斯坦-巴尔病毒(EBV)病毒衣壳抗原(VCA)IgG、VCA IgM和EBV核抗原1 IgG化学发光免疫分析法用于检测EBV抗体及对EBV感染状态进行分类的情况。
Clin Vaccine Immunol. 2014 May;21(5):684-8. doi: 10.1128/CVI.00104-14. Epub 2014 Mar 12.
9
Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.评估 Architect EBV VCA IgM、VCA IgG 和 EBNA-1 IgG 化学发光免疫分析,以评估移植前的 EBV 血清状态。
J Med Virol. 2017 Nov;89(11):2003-2010. doi: 10.1002/jmv.24889. Epub 2017 Aug 1.
10
Diagnostic Performance and Comparative Evaluation of the Architect, Liaison, and Platelia Epstein-Barr Virus Antibody Assays.Architect、Liaison 和 Platelia Epstein-Barr 病毒抗体检测分析的诊断性能和比较评估。
Ann Lab Med. 2018 Sep;38(5):458-465. doi: 10.3343/alm.2018.38.5.458.

引用本文的文献

1
Deciphering Positive Cytomegalovirus Immunoglobulin M Test Results in Immunocompetent Adults Hospitalized With Illness Suspicious for Acute Cytomegalovirus Infection: A Multihospital Study.解读免疫功能正常的成年住院患者巨细胞病毒免疫球蛋白M检测结果:这些患者因疑似急性巨细胞病毒感染而患病,一项多中心研究。
Open Forum Infect Dis. 2025 Mar 10;12(3):ofaf144. doi: 10.1093/ofid/ofaf144. eCollection 2025 Mar.
2
Diagnostic Performance and Comparative Evaluation of the Architect, Liaison, and Platelia Epstein-Barr Virus Antibody Assays.Architect、Liaison 和 Platelia Epstein-Barr 病毒抗体检测分析的诊断性能和比较评估。
Ann Lab Med. 2018 Sep;38(5):458-465. doi: 10.3343/alm.2018.38.5.458.
3
Cytomegalic hepatitis in a patient receiving omalizumab.接受奥马珠单抗治疗的患者发生巨细胞病毒性肝炎。
IDCases. 2016 Aug 11;5:83-4. doi: 10.1016/j.idcr.2016.08.001. eCollection 2016.
4
Evaluation of a standardised real-time PCR based DNA-detection method (Realstar®) in whole blood for the diagnosis of primary human cytomegalovirus (CMV) infections in immunocompetent patients.基于标准化实时荧光定量PCR的全血DNA检测方法(Realstar®)在免疫功能正常患者原发性人巨细胞病毒(CMV)感染诊断中的评估
Eur J Clin Microbiol Infect Dis. 2016 Feb;35(2):245-9. doi: 10.1007/s10096-015-2537-0. Epub 2015 Dec 10.
5
Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis.用于确定临床怀疑传染性单核细胞增多症的免疫功能正常青少年和年轻成人中EB病毒感染阶段的检验科EB病毒抗体检测组合的性能
Clin Vaccine Immunol. 2014 Jun;21(6):817-23. doi: 10.1128/CVI.00754-13. Epub 2014 Apr 2.
6
Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status.两种市售自动化免疫测定法用于确定爱泼斯坦-巴尔病毒血清学状态的性能。
Clin Vaccine Immunol. 2012 Jun;19(6):929-34. doi: 10.1128/CVI.00100-12. Epub 2012 Apr 25.
7
Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections.四种用于诊断爱泼斯坦-巴尔病毒原发性感染的商业系统的评估
Clin Vaccine Immunol. 2011 Mar;18(3):444-8. doi: 10.1128/CVI.00486-10. Epub 2010 Dec 29.
8
Multiplex detection of IgM and IgG class antibodies to Toxoplasma gondii, rubella virus, and cytomegalovirus using a novel multiplex flow immunoassay.使用新型多重流式免疫测定法对弓形虫、风疹病毒和巨细胞病毒的IgM和IgG类抗体进行多重检测。
Clin Vaccine Immunol. 2010 Nov;17(11):1734-8. doi: 10.1128/CVI.00332-10. Epub 2010 Sep 22.

本文引用的文献

1
Performance of the Epstein-Barr virus and herpes simplex virus immunoglobulin m assays on the liaison platform with sera from patients displaying acute parvovirus B19 infection.在Liaison平台上,使用患有急性细小病毒B19感染患者的血清,检测爱泼斯坦-巴尔病毒和单纯疱疹病毒免疫球蛋白M的性能。
Clin Vaccine Immunol. 2009 Aug;16(8):1247-8. doi: 10.1128/CVI.00142-09. Epub 2009 Jul 1.
2
Acute parvovirus B19 infection frequently causes false-positive results in Epstein-Barr virus- and herpes simplex virus-specific immunoglobulin M determinations done on the Liaison platform.急性B19微小病毒感染常导致在Liaison平台上进行的爱泼斯坦-巴尔病毒和单纯疱疹病毒特异性免疫球蛋白M检测出现假阳性结果。
Clin Vaccine Immunol. 2009 Mar;16(3):372-5. doi: 10.1128/CVI.00380-08. Epub 2008 Dec 30.
3
Evaluation of a multiplex flow immunoassay for detection of epstein-barr virus-specific antibodies.用于检测爱泼斯坦-巴尔病毒特异性抗体的多重流式免疫分析的评估
Clin Vaccine Immunol. 2008 Sep;15(9):1410-3. doi: 10.1128/CVI.00082-08. Epub 2008 Jul 16.
4
Laboratory assays for Epstein-Barr virus-related disease.爱泼斯坦-巴尔病毒相关疾病的实验室检测
J Mol Diagn. 2008 Jul;10(4):279-92. doi: 10.2353/jmoldx.2008.080023. Epub 2008 Jun 13.
5
Prevention of assay interference in infectious-disease serology tests done on the liaison platform.在Liaison平台上进行的传染病血清学检测中防止检测干扰
Clin Vaccine Immunol. 2008 May;15(5):891-2. doi: 10.1128/CVI.00012-08. Epub 2008 Mar 12.
6
Diagnostic evaluation of mononucleosis-like illnesses.传染性单核细胞增多症样疾病的诊断评估
Am J Med. 2007 Oct;120(10):911.e1-8. doi: 10.1016/j.amjmed.2006.12.011.
7
Serological diagnosis of infectious mononucleosis by chemiluminescent immunoassay using capsid antigen p18 of Epstein-Barr virus.采用爱泼斯坦-巴尔病毒衣壳抗原p18的化学发光免疫分析法对传染性单核细胞增多症进行血清学诊断。
Clin Chim Acta. 2005 Apr;354(1-2):77-82. doi: 10.1016/j.cccn.2004.11.010. Epub 2004 Dec 30.
8
Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.用于评估爱泼斯坦-巴尔病毒免疫状态的多重微珠检测法的评估
J Clin Microbiol. 2004 Nov;42(11):4996-5000. doi: 10.1128/JCM.42.11.4996-5000.2004.
9
Epstein-Barr virus infectious mononucleosis.爱泼斯坦-巴尔病毒感染性单核细胞增多症
Am Fam Physician. 2004 Oct 1;70(7):1279-87.
10
Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years.从实验室角度看常规爱泼斯坦-巴尔病毒诊断:35年后仍具挑战性。
J Clin Microbiol. 2004 Aug;42(8):3381-7. doi: 10.1128/JCM.42.8.3381-3387.2004.